Relationship features use of Quest's distributed network of
labs to deliver fast testing times in local communities around
the United States
LITTLETON, Colo., Oct. 5, 2023
/PRNewswire/ -- Neway, LLC, the U.S. leader in value-based dialysis
lab care, today announced a strategic lab services arrangement with
Quest Diagnostics (NYSE: DGX) that aims to accelerate dialysis
laboratory testing and reduce the laboratory costs of dialysis
programs for patients with end-stage renal disease (ESRD).
Under the terms of the agreement, Neway will utilize the
extensive lab network of Quest Diagnostics to provide local
dialysis laboratory testing services with typically next-day
results after arrival at a Quest Diagnostics laboratory. The
Neway-Quest collaboration will provide an alternative to the
centralized lab model where the majority of dialysis programs in
the U.S. transport specimens to a single laboratory for processing.
By utilizing Quest's distributed lab network, Neway and its
affiliated dialysis centers and their patients will experience
faster testing and results reporting and lower transportation
costs.
Bryan Thompson, Neway Founder and
CEO, said, "The Neway solution exemplifies our dedication to
bringing value, innovation, stewardship, and economies of scale to
the unique dialysis industry. The centralized dialysis laboratory
specimen testing model has been around since the early 1990s with
limited innovation. The old model of generally relying on air
transportation of dialysis laboratory specimens to a single U.S.
location is costly and can takes days for results. The 'new way'
for dialysis laboratory testing is a decentralized
network of laboratory locations that spans the nation. This
approach is good for dialysis patients, dialysis programs,
insurance payers, and the entire dialysis industry. It is a win for
everyone."
"As a leader in cardiometabolic diagnostic solutions, including
in kidney disease, Quest understands the unique challenges patients
with ESRD face and the criticality of rapid testing that never
compromises on quality," said Mouris
Saghir, PhD, Vice President and General Manager for the
Quest Diagnostics National Cardiometabolic Center of Excellence at
Cleveland HeartLab. "Working together with Neway, we will address
these challenges and expedite test results while maintaining the
highest level of quality for patients with ESRD."
View original content to download
multimedia:https://www.prnewswire.com/news-releases/neway-forms-lab-services-agreement-with-quest-diagnostics-to-speed-quality-esrd-testing-301949011.html
SOURCE Neway LLC